Technical aspects and clinical impact of hematopoietic progenitor subset quantification.
about
Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303Characterization of clonogenic progenitors in autologous peripheral blood stem cell grafts: evaluation of a simple in vitro assay suitable for routine clinical use.Quantification of nucleated red blood cells in allogeneic marrow graft and impact of processing on recovery.A European reference protocol for quality assessment and clinical validation of autologous haematopoietic blood progenitor and stem cell grafts.
P2860
Technical aspects and clinical impact of hematopoietic progenitor subset quantification.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Technical aspects and clinical impact of hematopoietic progenitor subset quantification.
@ast
Technical aspects and clinical impact of hematopoietic progenitor subset quantification.
@en
type
label
Technical aspects and clinical impact of hematopoietic progenitor subset quantification.
@ast
Technical aspects and clinical impact of hematopoietic progenitor subset quantification.
@en
prefLabel
Technical aspects and clinical impact of hematopoietic progenitor subset quantification.
@ast
Technical aspects and clinical impact of hematopoietic progenitor subset quantification.
@en
P2860
P1433
P1476
Technical aspects and clinical impact of hematopoietic progenitor subset quantification.
@en
P2093
P2860
P356
10.1634/STEMCELLS.18-2-76
P577
2000-01-01T00:00:00Z